Home > Industry Projects > Americas > Dendreon Biopharmaceutical Manufacturing Plant, Seattle
Provenge is expected to be approved by the FDA when additional evidence from clinical trials is produced.
Copyright 2007SPG Media Limited a subsidiary of SPG Media Group PLC
